Importantly, 2-DG treatment resulted in a reduction in gross splenic pathology in Il27ra-/- mice without impairing parasite control (Fig 5D), suggesting that increased glycolysis in the absence of IL-27 signalling may be targeted to reduce infection-induced inflammation, without impacting anti-parasitic immunity. The gene discussed is IL27; the disease is infection.